Found: 5

Select item for more details and to access through your institution.

  • Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.

    Published in:
    Biochemical Journal, 2015, v. 466, n. 1, p. 45, doi. 10.1042/BJ20141195
    By:
    • Varfolomeev, Eugene;
    • Izrael-Tomasevic, Anita;
    • Yu, Kebing;
    • Bustos, Daisy;
    • Goncharov, Tatiana;
    • Belmont, Lisa D.;
    • Masselot, Alexandre;
    • Bakalarski, Corey E.;
    • Kirkpatrick, Donald S.;
    • Vucic, Domagoj
    Publication type:
    Article

  • Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors.

    Published in:
    PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0109366
    By:
    • Wang, Weiru;
    • Elkins, Kristi;
    • Oh, Angela;
    • Ho, Yen-Ching;
    • Wu, Jiansheng;
    • Li, Hong;
    • Xiao, Yang;
    • Kwong, Mandy;
    • Coons, Mary;
    • Brillantes, Bobby;
    • Cheng, Eric;
    • Crocker, Lisa;
    • Dragovich, Peter S.;
    • Sampath, Deepak;
    • Zheng, Xiaozhang;
    • Bair, Kenneth W.;
    • O'Brien, Thomas;
    • Belmont, Lisa D.
    Publication type:
    Article

  • Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

    Published in:
    2011
    By:
    • Wertz, Ingrid E.;
    • Kusam, Saritha;
    • Lam, Cynthia;
    • Okamoto, Toru;
    • Sandoval, Wendy;
    • Anderson, Daniel J.;
    • Helgason, Elizabeth;
    • Ernst, James A.;
    • Eby, Mike;
    • Liu, Jinfeng;
    • Belmont, Lisa D.;
    • Kaminker, Joshua S.;
    • O'Rourke, Karen M.;
    • Pujara, Kanan;
    • Kohli, Pawan Bir;
    • Johnson, Adam R.;
    • Chiu, Mark L.;
    • Lill, Jennie R.;
    • Jackson, Peter K.;
    • Fairbrother, Wayne J.
    Publication type:
    Correction Notice

  • Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

    Published in:
    Nature, 2011, v. 471, n. 7336, p. 110, doi. 10.1038/nature09779
    By:
    • Wertz, Ingrid E.;
    • Kusam, Saritha;
    • Lam, Cynthia;
    • Okamoto, Toru;
    • Sandoval, Wendy;
    • Anderson, Daniel J.;
    • Helgason, Elizabeth;
    • Ernst, James A.;
    • Eby, Mike;
    • Jinfeng Liu;
    • Belmont, Lisa D.;
    • Kaminker, Josh S.;
    • O'Rourke, Karen M.;
    • Pujara, Kanan;
    • Kohli, Pawan Bir;
    • Johnson, Adam R.;
    • Chiu, Mark L.;
    • Lill, Jennie R.;
    • Jackson, Peter K.;
    • Fairbrother, Wayne J.
    Publication type:
    Article

  • Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 279, p. 1, doi. 10.1126/scitranslmed.aaa4642
    By:
    • Leverson, Joel D.;
    • Phillips, Darren C.;
    • Mitten, Michael J.;
    • Boghaert, Erwin R.;
    • Diaz, Dolores;
    • Tahir, Stephen K.;
    • Belmont, Lisa D.;
    • Nimmer, Paul;
    • Yu Xiao;
    • Xiaoju Max Ma;
    • Lowes, Kym N.;
    • Kovar, Peter;
    • Jun Chen;
    • Sha Jin;
    • Smith, Morey;
    • Xue, John;
    • Haichao Zhang;
    • Oleksijew, Anatol;
    • Magoc, Terrance J.;
    • Vaidya, Kedar S.
    Publication type:
    Article